Associate Director, GMAF - Bladder Cancer

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Medical Affairs Group

Job Sub Function:

Medical Affairs

Job Category:

People Leader

All Job Posting Locations:

Raritan, New Jersey, United States of America

Job Description:

Johnson & Johnson Innovative Medicine is recruiting for an Associate Medical Director for Bladder Cancer. The preferred location for this position is Raritan, NJ.

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

Purpose: The Associate Medical Director (AD), Medical Affairs, Bladder Cancer will be responsible for providing medical and scientific support aligned to the strategic objectives of Global Medical Affairs Bladder Cancer portfolio. Reporting to the Medical Head, Bladder Cancer, they will support the GMALs across activities to ensure cross-functional alignment and execution of the Global Medical Affairs strategy as outlined below:

• Generate a consolidated Medical Affairs strategy and tactical roadmap that integrates across medical affairs activities

• Support cross-functional teams to identify medical barriers and opportunities, help to prioritize and execute MAF led initiatives

• Provide subject matter support across the Bladder Cancer portfolio to support current and future indications with a strong understanding of the competitive landscape

• Drive the strategic vision for medical education content

• Drive Medical Affairs initiatives, including congress activities, advisory boards, steering committees, external engagements and core slide decks through innovative and creative content development

• Acts as standing or ad-hoc member for various cross-functional teams to provide SME expertise

Qualifications/Requirements

• A PhD, PharmD or MD is preferred

• Background in Bladder Cancer is preferred

• A minimum of three years of relevant experience in the pharmaceutical industry or equivalent experience is required

• Experience developing and executing medical launch strategies is preferred

• Experience developing congress strategies and prioritized KOL engagement is preferred

• Excellent written, oral and presentation skills are required

• Proven track record of developing, presenting and publishing clinical studies is preferred

• Strong organizational skills are a must

• A demonstrated ability to work in a matrix type environment with interaction with cross-functional teams is preferred.

• This position requires up to 25% annual travel (domestic and international).

• The anticipated base pay range for this position is $137,000.00 - 274,000.00 USD Annual

• The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation’s performance over a calendar/performance year. Bonuses are awarded at the Company’s discretion on an individual basis